Lethargy: Clinical Trials

3 trials for Lethargy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting. 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 3
Phase 12Recruiting 2

Follow Lethargy: new trials by email Literature Review of Lethargy trials Research Report on Lethargy

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
IRL757, Placebo - PARKINSON DISEASE (Disorder), Apathy
Phase 1 / Phase 2RecruitingIntegrative Research Laboratories AB752026-02-182026-09-03
Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia
intermittent theta burst stimulation (iTBS), Methylphenidate (MPH) - Alzheimer s Disease, Alzheimer Dementia (AD)
Phase 2RecruitingSunnybrook Health Sciences Centre122026-01-012025-12-12
Accelerated rTMS vs. Sham for Stroke Apathy
MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Active), MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Sham), Brainsight Neuronavigation System - Apathy, Stroke
Phase 1 / Phase 2RecruitingMedical University of South Carolina402025-08-082026-07-08

Narrower conditions

Alzheimer Disease (1)  ·  Dementia (1)  ·  Depression (1)  ·  Ischemia (1)  ·  Parkinson Disease (1)  ·  Stroke (1)

Broader conditions

Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Nervous System Diseases (3)  ·  Neurobehavioral Manifestations (3)  ·  Neurologic Manifestations (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Neurodegenerative Diseases (2)  ·  Basal Ganglia Diseases (1)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Cardiovascular Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Mental Disorders (1)  ·  Movement Disorders (1)

Interventions

Drug Delivery Systems (1)  ·  Methylphenidate (1)  ·  Transcranial Magnetic Stimulation (1)

Sponsors

Integrative Research Laboratories AB (1)  ·  Medical University of South Carolina (1)  ·  Sunnybrook Health Sciences Centre (1)

Countries

Bulgaria (1)  ·  Canada (1)  ·  Germany (1)  ·  Poland (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Kevin Caulfield, PhD (1)  ·  Krista Lanctot, PhD (1)  ·  Lisa McTeague, PhD (1)  ·  Parneet Grewal, PhD (1)